Osmetech Submits Request to FDA for Swine Flu Test | GenomeWeb

NEW YORK (GenomeWeb News) – UK-based molecular diagnostics company Osmetech announced today that it has submitted a request to the US Food and Drug Administration for Emergency Use Authorization for its swine flu test.

The company's Respiratory Pathogen Test Panel detects 18 bacteria and viruses commonly involved in infection, including the influenza A virus and the H1N1 subtype linked to the recent swine flu pandemic.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nucleic Acids Research this week: nanopore sequencing workflow to detect antibiotic resistance in gut microbes, TSSPlant tool, and more.

Because gene-edited organisms can cross borders, Gizmodo wonders whether there should be an international body to govern their use.

HHS Secretary nominee Tom Price is to go in front of the Senate Committee on Health, Education, Labor and Pensions today, NPR's Morning Edition reports.

Prior to being closed, Theranos' Arizona lab failed an inspection by regulators, according to the Wall Street Journal.